Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$128.91 - $192.44 $26,039 - $38,872
-202 Reduced 6.97%
2,698 $370,000
Q2 2023

Aug 08, 2023

SELL
$183.43 - $232.67 $11,005 - $13,960
-60 Reduced 2.03%
2,900 $543,000
Q1 2023

May 08, 2023

BUY
$193.75 - $232.55 $106,368 - $127,669
549 Added 22.77%
2,960 $688,000
Q4 2022

Feb 06, 2023

BUY
$187.24 - $242.74 $182,184 - $236,186
973 Added 67.66%
2,411 $488,000
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $23,748 - $30,476
-134 Reduced 8.52%
1,438 $274,000
Q2 2022

Aug 05, 2022

SELL
$181.58 - $368.0 $19,792 - $40,112
-109 Reduced 6.48%
1,572 $290,000
Q1 2022

May 10, 2022

BUY
$303.87 - $423.8 $1,519 - $2,119
5 Added 0.3%
1,681 $587,000
Q4 2021

Feb 07, 2022

SELL
$347.28 - $421.83 $21,878 - $26,575
-63 Reduced 3.62%
1,676 $638,000
Q3 2021

Nov 10, 2021

BUY
$405.61 - $524.84 $14,196 - $18,369
35 Added 2.05%
1,739 $705,000
Q2 2021

Aug 04, 2021

BUY
$372.84 - $481.5 $13,049 - $16,852
35 Added 2.1%
1,704 $806,000
Q1 2021

May 10, 2021

BUY
$361.28 - $504.76 $4,696 - $6,561
13 Added 0.79%
1,669 $641,000
Q4 2020

Feb 08, 2021

BUY
$292.7 - $370.96 $484,711 - $614,309
1,656 New
1,656 $613,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.